FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119371605> ?p ?o ?g. }

• W3119371605 endingPage "3176" @default.
• W3119371605 startingPage "3164" @default.
• W3119371605 abstract "Purpose: To analyze different clinical and anatomical features in treatment-naïve non-exudative macular neovascularizations (MNVs) secondary to age-related macular disease (AMD). Methods: In this retrospective longitudinal study with a minimum follow-up of 1 year, 31 eyes of 28 consecutive AMD patients (mean age 75 ± 9 years) with treatment-naïve non-exudative MNV were enrolled. Patients were divided in: short-term activated MNV group (exudation before 6-month) and quiescent MNV group (per definition no exudation during a minimum 6-month follow-up) showing no or late activation during follow-up (persistently quiescent and long-term activated MNV group, respectively). Results: During the follow-up (mean duration: 22 ± 9 months) four eyes (13%) showed exudation before 6-month follow-up (short-term activated MNV group), whereas 21 eyes (68%) did not develop signs of exudation (persistently quiescent group), and six eyes (19%) developed exudation after the minimum 6-month follow-up (long-term activated MNV group). Monthly MNV growth rate was significantly higher in the short-term activated MNV group (growth rate of 13.30%/month), vs persistently quiescent MNV group (0.64%/month, p < 0.001) and long-term activated quiescent MNV group (1.07%/month, p < 0.001). Furthermore, at the baseline, perfusion density of short-term activated MNV group was significantly greater in comparison to persistently quiescent MNV group ( p = 0.001) and long-term activated MNV group ( p = 0.106). Conclusion: We reported two different patterns for subclinical MNVs: subclinical MNVs characterized by short-term activation which could represent simply a pre-exudative stage in the development of an ordinary type 1 MNV, and quiescent MNVs characterized by low rate of growth and possible long-term activation. Analysis of OCT-A features may predict short-term activation for subclinical MNV but no features could predict the long-term activation." @default.
• W3119371605 created "2021-01-18" @default.
• W3119371605 creator A5003486682 @default.
• W3119371605 creator A5010933792 @default.
• W3119371605 creator A5013999026 @default.
• W3119371605 creator A5014284905 @default.
• W3119371605 creator A5022647583 @default.
• W3119371605 creator A5023501291 @default.
• W3119371605 creator A5025381565 @default.
• W3119371605 creator A5057607340 @default.
• W3119371605 creator A5058245918 @default.
• W3119371605 creator A5067179409 @default.
• W3119371605 creator A5067856376 @default.
• W3119371605 creator A5077720400 @default.
• W3119371605 date "2021-01-14" @default.
• W3119371605 modified "2023-09-30" @default.
• W3119371605 title "Treatment-naïve quiescent macular neovascularization secondary to AMD: The 2019 Young Investigator Lecture of Macula Society" @default.
• W3119371605 cites W159419684 @default.
• W3119371605 cites W1972642682 @default.
• W3119371605 cites W2037008229 @default.
• W3119371605 cites W2058266372 @default.
• W3119371605 cites W2059258588 @default.
• W3119371605 cites W2092103332 @default.
• W3119371605 cites W2252750661 @default.
• W3119371605 cites W2306360473 @default.
• W3119371605 cites W2322602077 @default.
• W3119371605 cites W2471585803 @default.
• W3119371605 cites W2522606404 @default.
• W3119371605 cites W2547788753 @default.
• W3119371605 cites W2589314360 @default.
• W3119371605 cites W2737253305 @default.
• W3119371605 cites W2758418434 @default.
• W3119371605 cites W2761892881 @default.
• W3119371605 cites W2766279308 @default.
• W3119371605 cites W2777825356 @default.
• W3119371605 cites W2789485032 @default.
• W3119371605 cites W2789909859 @default.
• W3119371605 cites W2804685255 @default.
• W3119371605 cites W2810620275 @default.
• W3119371605 cites W2898428450 @default.
• W3119371605 cites W2907936264 @default.
• W3119371605 cites W2908926515 @default.
• W3119371605 cites W2915287869 @default.
• W3119371605 cites W2925297839 @default.
• W3119371605 cites W2937654389 @default.
• W3119371605 cites W2952089595 @default.
• W3119371605 cites W2979235338 @default.
• W3119371605 cites W3014055993 @default.
• W3119371605 doi "https://doi.org/10.1177/1120672120986370" @default.
• W3119371605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33445977" @default.
• W3119371605 hasPublicationYear "2021" @default.
• W3119371605 type Work @default.
• W3119371605 sameAs 3119371605 @default.
• W3119371605 citedByCount "6" @default.
• W3119371605 countsByYear W31193716052021 @default.
• W3119371605 countsByYear W31193716052022 @default.
• W3119371605 countsByYear W31193716052023 @default.
• W3119371605 crossrefType "journal-article" @default.
• W3119371605 hasAuthorship W3119371605A5003486682 @default.
• W3119371605 hasAuthorship W3119371605A5010933792 @default.
• W3119371605 hasAuthorship W3119371605A5013999026 @default.
• W3119371605 hasAuthorship W3119371605A5014284905 @default.
• W3119371605 hasAuthorship W3119371605A5022647583 @default.
• W3119371605 hasAuthorship W3119371605A5023501291 @default.
• W3119371605 hasAuthorship W3119371605A5025381565 @default.
• W3119371605 hasAuthorship W3119371605A5057607340 @default.
• W3119371605 hasAuthorship W3119371605A5058245918 @default.
• W3119371605 hasAuthorship W3119371605A5067179409 @default.
• W3119371605 hasAuthorship W3119371605A5067856376 @default.
• W3119371605 hasAuthorship W3119371605A5077720400 @default.
• W3119371605 hasConcept C113280763 @default.
• W3119371605 hasConcept C118487528 @default.
• W3119371605 hasConcept C126322002 @default.
• W3119371605 hasConcept C141071460 @default.
• W3119371605 hasConcept C2776403814 @default.
• W3119371605 hasConcept C2781359195 @default.
• W3119371605 hasConcept C71924100 @default.
• W3119371605 hasConceptScore W3119371605C113280763 @default.
• W3119371605 hasConceptScore W3119371605C118487528 @default.
• W3119371605 hasConceptScore W3119371605C126322002 @default.
• W3119371605 hasConceptScore W3119371605C141071460 @default.
• W3119371605 hasConceptScore W3119371605C2776403814 @default.
• W3119371605 hasConceptScore W3119371605C2781359195 @default.
• W3119371605 hasConceptScore W3119371605C71924100 @default.
• W3119371605 hasIssue "6" @default.
• W3119371605 hasLocation W31193716051 @default.
• W3119371605 hasLocation W31193716052 @default.
• W3119371605 hasOpenAccess W3119371605 @default.
• W3119371605 hasPrimaryLocation W31193716051 @default.
• W3119371605 hasRelatedWork W1125304470 @default.
• W3119371605 hasRelatedWork W1157662124 @default.
• W3119371605 hasRelatedWork W1189403540 @default.
• W3119371605 hasRelatedWork W2033066615 @default.
• W3119371605 hasRelatedWork W2616362931 @default.
• W3119371605 hasRelatedWork W2994351038 @default.
• W3119371605 hasRelatedWork W4251170123 @default.
• W3119371605 hasRelatedWork W864042182 @default.
• W3119371605 hasRelatedWork W970421003 @default.

• next